(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-05-19 View latest technical analysis
10 day averaged volume of Corvus Pharmaceuticals is 2188060
| Date | Daily Closing Price | Open | High | Low | Volume |
| 19 Mon May 2025 | 3.62 | 3.56 | 3.72 | 3.52 | 0.326 times |
| 16 Fri May 2025 | 3.61 | 3.62 | 3.77 | 3.50 | 0.478 times |
| 15 Thu May 2025 | 3.58 | 3.59 | 3.60 | 3.46 | 0.302 times |
| 14 Wed May 2025 | 3.62 | 3.88 | 3.90 | 3.47 | 0.537 times |
| 13 Tue May 2025 | 3.89 | 4.07 | 4.11 | 3.88 | 0.391 times |
| 12 Mon May 2025 | 4.06 | 4.42 | 4.53 | 3.84 | 1.155 times |
| 09 Fri May 2025 | 4.43 | 4.22 | 4.49 | 3.93 | 4.047 times |
| 08 Thu May 2025 | 3.35 | 3.19 | 3.49 | 3.17 | 2.152 times |
| 07 Wed May 2025 | 3.20 | 3.38 | 3.38 | 3.17 | 0.359 times |
| 06 Tue May 2025 | 3.35 | 3.56 | 3.56 | 3.33 | 0.332 times |
My analysis of stock is bullish for shortterm, and stock might move up till 3.9 or till 4.2. Use a stoploss of 3.6 and if this stock hits its stoploss, then it can fall down till 3.33
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 2.54 |
| Downside Target | 3.08 |
| Downside Target | 3.15 |
| Downside Target | 3.41 |
| Upside Target | 3.72 |
| Upside Target | 4.49 |
| Upside Target | 4.53 |
| Upside Target | 4.60 |
| Upside Target | 4.80 |
| Upside Target | 5.65 |
| Upside Target | 6.47 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 3.52 |
| Downside Intraday Target | 3.42 |
| Upside Intraday Target | 3.72 |
| Upside Intraday Target | 3.82 |
| Downside Intraday Target | 3.62 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 19 Mon May 2025 | 3.62 | 3.56 | 3.72 | 3.52 | 0.114 times |
| 16 Fri May 2025 | 3.61 | 4.42 | 4.53 | 3.46 | 0.401 times |
| 09 Fri May 2025 | 4.43 | 3.58 | 4.49 | 3.17 | 3.773 times |
| 02 Fri May 2025 | 3.62 | 3.70 | 3.76 | 3.41 | 0.868 times |
| 25 Fri Apr 2025 | 3.63 | 3.21 | 3.78 | 3.15 | 6.154 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 19 Mon May 2025 | 3.62 | 3.58 | 4.53 | 3.17 | 1.363 times |
| 30 Wed Apr 2025 | 3.59 | 3.22 | 3.78 | 2.54 | 1.648 times |
| 31 Mon Mar 2025 | 3.18 | 4.10 | 4.80 | 3.08 | 1.037 times |
| 28 Fri Feb 2025 | 4.04 | 5.17 | 5.65 | 3.85 | 0.874 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term but the buy signal is initial and weak.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.92 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term but the buy signal is initial and weak.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.92 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.